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ABSTRACT
Objective: The objective of this study was to determine the new bioactive compounds through gas chromatography–mass spectrometry analysis and 
the cytotoxic activity of two rodent tuber mutant plants against breast cancer cells (MCF-7).
Methods: The bioactive compounds in rodent tuber mutant plants were successfully increased by somaclonal variation using gamma rays 
irradiation technique. Further, the cytotoxicity activity of rodent tuber mutant plants was tested on breast cancer cell line (MCF-7) performed by 
3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide assay method.
Results: This results study confirmed that the presence of phytochemical composition in the tuber of rodent tuber mutant plants KB 6–1–3–4 and 
KB 6–9–5 was found six bioactive compounds from fatty acid groups which have the potential as an anticancer compound, such as octadecanoic acid, 
hexadecanoic acid, hexadecanoic acid methyl ester, 9-octadecanoic acid, linolelaidic acid methyl ester, and butanoic acid. The results showed that 
extracts from rodent tuber mutant plants had a cytotoxicity effect on MCF-7 cancer cells with half maximal inhibitory concentration (IC50) values that 
were lower than the control (mother plant). In vitro tests of KB 6–1–3–4 and KB 6–9–5 against MCF-7 cancer cell lines have IC50 values of 12.482 μg/mL 
and 7.043 μg/mL, respectively, while it had a lower cytotoxicity effect with the IC50 value of control plant was 19.113 μg/mL. The mutant plants of KB 
6-9-5 have 3 times more effective than control.
Conclusion: The results of this study clearly indicated that rodent tuber mutant plants have shown promising as an anticancer drug on breast cancer.
Keywords: Typhonium flagelliforme Lodd., Anticancer, MCF-7 cell, Gas chromatography–mass spectrometry analysis, Fatty acids.
INTRODUCTION
Rodent tuber (Typhonium flagelliforme Lodd.) is the Araceae family and 
classified as herbal plants [1]. Plant propagation methods are carried 
out vegetatively by separating the shoots [1]. Many studies investigated 
that rodent tuber has bioactive compounds as anticancer, antiviral, 
antibacterial, and antioxidant agents [2-4]. Rodent tuber was found to 
possess useful anticancer activities such as in breast, intestine, prostate 
gland, liver, leukemia, and cervix [2,5,6]. In vitro mutagenesis was carried 
out using a combination of gamma-ray irradiation and somaclonal 
variation to increase the bioactive compounds in rodent tuber plants. 
The rodent tuber mutant plants have morphology changes [7], genetic 
changes [8,9], and protein expression changes [10]. Morphological, 
genetic, and protein expression changes can reinforce the bioactive 
compounds in mutant plants. Sianipar and Purnamaningsih [11] had 
investigated that bioactive compounds in several mutant clones from 
Bogor have been increased.
Genetic mutations can be used and the number of phytochemical 
components in plants, which can be detected by gas chromatography–
mass spectrometry (GC–MS). GC–MS has been used to determine 
the content of herbal plants such as Melia orientalis [12], Maranta 
arundinacea L. [13], and non-polar fractions of Malaysian rodent 
tuber [6]. Extracts of the rodent tuber plant have been applied to several 
cancer cells in vitro. Rodent tuber extract with ethanol fraction has been 
shown to be effective in inhibiting the growth of T47D breast cancer 
cells [14], inhibiting the proliferation of T4-lymphoblastoid human 
cancer cells [4,5] and can inhibit the growth of cell cultures of non-small 
cell lung carcinoma NCI-H23 [2]. The anticancer activity test can be 
carried out by antiproliferative extract test on the growth of cancer cells 
using the clonogenic assay method [15,16]. The 3-(4,5-dimethythiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) method has been used to 
determine anticancer activity in rodent tuber [2,4,14]. The aimed of this 
study was to determine the new bioactive compounds through GC–MS 
analysis and has a cytotoxic activity of two mutant clones (KB 6–1–3–4 
and KB 6–9–5) against MCF-7 breast cancer cell lines.
METHODS
Plant material
Rodent tuber plant material is used from Bogor. Rodent tuber has been 
irradiated by gamma-ray to produce in vitro mutagenesis and obtained 
rodent tuber mutant plants. Two mutant plants of KB 6-1-3-4, KB 6-9-5, 
and control plant (mother plant) were acclimatized and maintained 
at Indonesian Center for Agricultural Biotechnology and Genetic 
Resources Research and Development, Ministry of Agriculture, Bogor, 
Indonesia. The rodent tuber mutant plants were harvested and dried to 
extract all substances.
Preparation of rodent tuber mutant extract
Rodent tuber mutant plants KB 6-1-3-4, KB 6-9-5, and control plants 
were harvested and cleaned the tubers, then cut into small pieces 
and weighed. The tuber samples were macerated using ethanol for 
24 h, 2 times repetition [17]. The samples were filtered using Whatman 
paper No.1, and the filtrate was evaporated using a rotary evaporator at 
40°C to obtain a crude extract of rodent tuber. Extraction results are put 
into a sample bottle and dried using freeze drier.
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GC–MS analysis
The ethanol fraction of the sample was injected into the GC column. 
The injection volume of the extraction solution was 5 μl with a 5:1 
split ratio and an injection temperature of 250°C. Helium is used as a 
carrier gas with a speed of 0.8 μl per min. The column temperature was 
set at 70°C with an increase of 50°C per min. When the temperature 
reaches 200°C, it remains constant for 1 min and then increases at a 
rate of 20°C/min until the temperature reaches 280°C. The temperature 
remains constant for 28 min. The mass spectrometer was operated in 
electron ionization mode with a voltage of 70 eV.
Identification of phytochemical compounds
GC–MS mass spectrum identification was carried out with reference 
to the National Institute of Standards and Technique database with a 
factor of fit ≥90% [18]. Percentage of the relative abundance of each 
compound was calculated by comparing the average peak area with the 
total area.
In vitro screening test of cancer cell cytotoxicity and data analysis
Cytotoxic activity against breast cancer cells (MCF-7) performed by 
MTT assay method. 100 μL of suspension 103 cells were cultured and 
seeded into 96-well disk plate, and incubated at 37°C for 24 h. 100 μL 
of medium containing rodent tuber extract with serial concentration 
obtained 1000, 500, 250, 125, and 62.5 μg/mL of test solution added 
to each well and the dish was incubated at 37°C for 24 h. At the end 
of the incubation, the culture media containing the sample was 
removed and washed with 100 μL phosphate-buffered saline. In each 
single well was added 100 µL of culture medium containing MTT and 
reincubated for 4 h at 370°C. The live cells will react with MTT to 
form purple formazan. After 4 h, at each well, the stopper reagent was 
added to kill cells and dissolved formazan crystals. Plate in a shaker for 
10 min, then incubated at room temperature in a dark room overnight. 
Furthermore, the absorbance of each well was read by the ELISA reader 
with absorbance at a wavelength of 595 nm, and the percentage of 
cell viability of MCF-7 or cell proliferation inhibition percentage was 
calculated. A dose of test solution that reduces survival by half maximal 
inhibitory concentration (IC50) was calculated. Cisplatin was used as a 
positive control while control plant was used as a negative control. The 
cytotoxic activity of rodent tuber mutant plants was expressed with 
IC50 values  obtained through a linear regression analysis between the 
logarithm of the concentration of the test material and the percentage 
of MCF-7 cell viability.
RESULTS
The bioactive compounds in the tuber of mutant clones extract have 
been identified using GC–MS analysis. Based on the GC–MS analysis, 
there were differences in the phytochemical composition between 
the tuber of control and mutant plants (Table 1). This study evaluated 
that the phytochemical composition in the tubers of KB 6–1–3–4 
and KB 6–9–5 mutant clones was increased and found new bioactive 
compounds which not present in the control plant (Table 1). The tubers 
of mutant clones contained several new anticancer compounds which 
were not found in control (Table 2 and Fig. 1).
The results of this study revealed that six bioactive compounds from 
fatty acid have potential as anticancer activity is octadecanoic acid, 
hexadecanoic acid, hexadecanoic acid methyl ester, 9-octadecanoic 
acid, linolelaidic acid methyl ester, and butanoic acid (Table 2). Some 
anticancer compounds in mutant clones have a higher amount than 
control plant. The most potential target as anticancer properties 
among six bioactive compounds from fatty acid is octadecanoic acid 
and hexadecanoic acid. Octadecanoic acid has the most different 
anticancer properties with the relative abundance. The octadecanoic 
acid was absent in the control plant. As shown in Table 2, octadecanoic 
acid in the KB 6-9-5 has higher concentrations of about 85.03%. This 
study confirmed that KB 6-9-5 has potency as anticancer agent 2 times 
greater than KB 6-1-3-4 mutant clones.
Table 1: Phytochemical composition in the tubers extraction of rodent tuber control and mutant clones based on GC–MS
Name of compound RT Area percentage
Control 6-1-3-4 6-9-5 Control 6-1-3-4 6-9-5
Hexadecanoic acid 31.954 28.889 28.861 22.08 4.46 3.99
Hexadecanoic acid, methyl ester NI 28.331 NI NI 2.86 NI
Octadecanoic acid NI 89 30.144 NI 8.07 85.03
9-Octadecanoic acid, methyl ester NI 29.517 NI NI 2.39 NI
9,12-Octadecadienoic acid 33.078 NI NI 38.37 NI NI
Campesterol 40.532 NI NI 1.55 NI NI
Alpha-monopalmitin NI NI 38.439 NI NI 1.07
Stigmasterol 40.966 NI NI 4.05 NI NI
Butanoic acid NI 28.820 NI NI 2.53 NI
2-Acetyl-2-thiazoline NI NI 29.510 NI NI 1.09
Linolelaidic acid, methyl ester NI 29.489 NI NI 6.09 NI
N-Acetyl-d, 1-norleucenine NI 29.648 NI NI 2.23 NI
11-Dodecenyl trifluoroacetate NI 29.985 NI NI 47.64 NI
1-Acetoxynonane NI 31.571 NI NI 2.72 NI
(Z, Z)-3,6-Nonadienal NI 32.578 NI NI 7.28 NI
1-Tridecene NI 37.970 NI NI 2.90 NI
1,5-Heptadiene, 3,3,5-trimethyl NI 38.543 NI NI 4.93 NI
Table 2: Fatty acid composition as anticancer properties in the tubers extraction of rodent tuber mutant clones
Anticancer properties reference Name of the compound Nature of the compound RT Area percentage
6-1-3-4 6-9-5 6-1-3-4 6-9-5
[19,20] Hexadecanoic acid Palmitic acid 28.889 28.861 4.46 3.99
[21] Hexadecanoic acid, methyl ester Palmitic acid, methyl ester 28.331 NI 2.86 NI
[19,22] Octadecanoic acid Stearic acid 89 30.144 8.07 85.03
[19,23] 9-Octadecanoic acid, methyl ester Omega-9/elaidic acid 29.517 NI 2.39 NI
[2] Linolelaidic acid, methyl ester Omega-6 29.489 NI 6.09 NI
[25-27] Butanoic acid Butyric acid 28.820 NI 2.53 NI
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The result of MTT assays was obtained from the linear regression equation 
between concentration and percent of living cells. The results showed 
that the tubers extract from two mutant clones significantly inhibited the 
MCF-7 cell line and had potent extract with IC50 value of 12.482 μg/mL 
from KB 6-1-3-4 and 7.043 μg/mL from KB 6-9-5. All the tubers extract 
from two mutant clones showed cytotoxic effect toward MCF-7 cell line. 
According to the U.S. The National Cancer Institute (NCI), a compound 
has cytotoxic activity if it has IC50 values of <20 μg/mL [28,29]. Based 
on the IC50 values of the two rodent tuber mutant plants, the IC50 values 
of <20 μg/mL so that it can be confirmed that both KB 6–1–3–4 and KB 
6–9–5 have cytotoxic activity against MCF-7 cell line. The results of this 
study showed a linear relationship between IC50 values of KB 6–1–3–4 
and KB 6–9–5 with a percentage of viability of living cells (Fig. 2). The IC50 
value of the control rodent tuber plant was 19.1131 μg/mL. The result of 
MTT assay on rodent tuber mutant plant’s extract KB 6-9-5 was 3 times 
more effective than compared to control plant.
DISCUSSION
Octadecanoic acid or stearic acid is a saturated fatty acid found in 
relatively high concentrations in some foods. Octadecanoic acid or stearic 
acid is the primary metabolites present in plants which form of glycerol 
esters [30]. Stearic acid has been reported to inhibit the development 
of human breast cancer cells in proliferation in vitro [31-33] and 
in vivo [34]. Stearic acid has also been shown to induce apoptosis in 
breast cancer cells and inhibit cell cycle of breast tumors [35,36]. 
Interestingly, epidemiological studies have also shown that stearic acid 
has the potential to prevent and treat breast cancer [37].
Hexadecanoic acid or palmitic acid has been shown to have antitumor 
activity in mouse models and is cytotoxic selective for MOLT-4 leukemia 
cancer cells due to their interaction with DNA topoisomerase I and 
their ability to induce apoptosis [24]. Palmitic acid was present in 
Solanum nigrum which had a role induce apoptosis on cervical 
cancer cell lines [38]. The hexadecanoic acid methyl ester is also 
able to inhibit growth and induce apoptosis of human gastric cancer 
cells [39]. Hexadecanoic acid methyl ester has been found to have anti-
Fig 2: The graph represents the cell proliferation inhibition 
of tuber mutant plants (KB 6–1–3–4 and KB 6–9–5) against 
MCF-7 breast cancer cell lines at different concentrations 
(62.5–1000 µg mL-1). Data were plotted as a percentage of cell 
proliferation inhibition and represented as mean ± standard 
error mean (SEM) of three independent experiments
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inflammatory, antioxidant, hypocholesterolemic, 5-alpha reductase 
inhibitors, nematicide, pesticides, and antiandrogenic [40].
Fatty acid compounds in herbal plants have a role as chemopreventive 
agents or cause cell cycle inhibition and trigger apoptosis in cancer 
cells [41]. The results of this study revealed that a lower IC50 value 
indicates a higher anticancer activity. This study shows that the fatty 
acids from octadecanoic acid and hexadecanoic acid are responsible 
for their pharmacological activity and their extract produces a 
chemopreventive agent effect or causes inhibition of the growth cycle 
of cancer cells [42]. The rodent tuber mutant plants showed a potential 
source that can be used as an alternative treatment for breast cancer 
from natural ingredients. In the previous study, Purwaningsih et al. [43] 
conducted cytotoxic tests from the leaves of rodent tuber extracts 
against HeLa and MCF-7 cells produced IC50 values of 30.19 μg/mL, 5.58 
μg/mL, respectively, whereas in the study of Purwaningsih et al. [44,45] 
obtained by rodent tuber extract can reduce telomerase expression in 
HeLa and Raji cells.
This study showed that KB 6–1–3–4 and KB 6–9–5 extracts have the 
strong potential as anticancer agents through inhibition of MCF-7 
cancer cell. Mohan et al. [4] have examined that the cytotoxic effects of 
the crude extracts of rodent tuber plants using dichloromethane and 
ethyl acetate on leukemia cancer cells (T4-lymphoblastoid CEM-ss) 
have a significant effect in inhibiting cell invasion and experiencing 
apoptosis for 72 h, at IC50 values of 6.5 and 8.2 μg/mL. Antitumor and 
cytotoxic effects have been observed for the chemical compounds 
methyl esters [46] and other evidence suggests that amino acid methyl 
esters produce high cytotoxic effects on MCF-7 cells [35]. In addition, 
as shown in the study of Hardy et al. [47], octadecanoic acid induces 
apoptosis of breast cancer cells through mechanisms that might have 
implications for increased cardiolipin replacement and a reduction of 
mitochondrial phospholipids.
CONCLUSION
Mutant clones of KB 6–1–3–4 and KB 6–9–5 concluded that have an 
important role and offer a new potential promising as anticancer agents on 
breast cancer cell. Octadecanoic acid (stearic acid) and hexadecanoic acid 
(palmitic acid) are the major role of bioactive compounds as anticancer. 
The cytotoxicity test through MTT on MCF-7 cancer cells obtained by 
KB 6-9-5 mutant clone has higher IC50 values of 7.043 μg/mL which 
compared with the IC50 values in control plants about 19.113 μg/mL. 
KB 6-9-5 mutant clone has greater effectiveness up to 5 times compared 
to control plants. KB 6–1–3–4 and KB 6–9–5 showed more effective as 
anticancer against in vitro MCF-7 breast cancer cells. The further study is 
needed to investigate the effect of rodent tuber mutant plants extract on 
activity apoptosis and telomerase in MCF-7 breast cancer cell lines.
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